The first sequencing of the human genome in 2000 by Dr. Venter and colleagues provided a glimpse of humans at our most basic molecular level. JCVI's most recent publication of the first diploid human genome â€”Â the genome of one individual in which both sets of inherited chromosomes were presented, represents a major step forward in the enablement of individualized genomic medicine and in enhanced understanding of human biology.
The Genomic Medicine Group at JCVI has been at the forefront of human genomics research and they continue their focus on providing a better molecular understanding of human health and disease propensity by further study of this first diploid human genome. The team is setting the stage for more individual genomes to be sequenced and analyzed over the next decade since a deep understanding of disease will only be possible by having many sequenced genomes available for comparison.
The team is also working in collaboration with several groups to better understand the genomic basis for some of the most prevalent and vexing diseases such as cancer and diseases of the heart, lungs, and blood.
A yeast two-hybrid screen will help us to discover all protein-protein interactions in E. coli, an important pathogen and model organism.
We are developing methods to discover genetic variants associated with disease â€”Â an important step toward personalized medicine.
The first publication of a diploid human genome from one person: A step closer to truly individualized genomic medicine.
The NIH Human Microbiome Project (HMP) was initiated to help determine the core human microbiome, to understand the changes in the human...
As a leading genomics research organization, the J. Craig Venter Institute has numerous projects and programs that are focused on this...
We are developing methods using single cell genomics & MDA to obtain bacterial genomes from human specimens to discover their roles in...
Research Team led by JCVI Scientists Uncover More Complexity and Detail in Southern African Genomic Diversity.